What is mass spectrometry oncology ?

Mass spectrometry (MS) is a powerful molecular detection technology that can accurately measure the atomic or molecular composition of biological samples, providing information about specific molecules in the sample. In oncology, MS can be used for the diagnosis and treatment of tumors.

The research field of mass spectrometry oncology is very broad, including but not limited to the following areas:

1.Discovery and identification of tumor markers: MS can be used to detect differences between tumor cells and normal cells, looking for biomarkers that can be used for tumor diagnosis and prognosis prediction.

2.Drug development and treatment monitoring: MS can be used to monitor the response of tumor cells to drugs, as well as drug metabolism and distribution in the body, thereby optimizing drug treatment plans.

3.Genetic research on tumors: MS can be used to analyze the genome, transcriptome, and proteome of tumor cells, revealing the mechanism of tumor occurrence and development, as well as the molecular characteristics of different tumor types.

4.Clinical trials and precision medicine: MS can be applied in clinical trials to analyze tumor samples of patients, providing personalized treatment plans and prognosis predictions for patients.

In summary, mass spectrometry oncology is a research field based on MS technology in oncology, aiming to improve the accuracy of tumor diagnosis, enhance the therapeutic effect and quality of life of patients.